Image Analysis Group (IAG) – Blog & Insights

Latest Company News DYNAMIKA Spotlight Events IAG Partnerships Industry Digest Knowledge Base

Image Analysis Group (IAG) at HBI 2026 pharma services panel in Paris discussing AI-driven imaging for clinical trials.

Company News March 17, 2026

Image Analysis Group (IAG) to Join High-Profile Pharma Services Panel at HBI 2026 in Paris

March 16, 2026

IMAGE ANALYSIS GROUP (IAG) ACHIEVES SOC 2 TYPE II CERTIFICATION

Example 18F-NaF PET/MRI from the S-OLARIS trial showing a 43% reduction in sacroiliac joint SUVmax at week 12, illustrating SLK’s deep, disease‑modifying effects on bone remodelling in axial spondyloarthritis.

March 13, 2026

Beyond the MRI: How PET Imaging is Redefining Drug Development in Axial Spondyloarthritis

IAG Monthly Newsletter February 2026 - Smarter Oncology Trials with AI and Imaging

March 11, 2026

IAG Monthly Newsletter |🔎Smarter Oncology Trials with AI & Imaging

Neuro-oncology clinical trial targeting brain tumor - Image Analysis Group (IAG) smart solutions for glioblastoma and CNS drug development

March 10, 2026

Neuro-Oncology Trials: Key Challenges & Smart Solutions for Drug Developers

Biotech wins and oncology pipeline growth chart - Image Analysis Group (IAG)

Industry Digest March 10, 2026

Key Biotech Wins in 2025 and Strategic Priorities for Drug Developers in 2026

Oncology clinical trial imaging and protocol endpoint strategy - Image Analysis Group (IAG)

Company News March 9, 2026

Protocol and Endpoint Considerations in Oncology Trials

Centralized Imaging Review in Immuno-Oncology Trials — Reducing Variability & Improving Endpoint Reliability | IAG Image Analysis Group

Company News March 9, 2026

How Centralized Imaging Reduces Variability in Immuno-Oncology Trials

Psoriatic arthritis imaging: hand joint inflammation used in whole-body MRI clinical trial scoring.

DYNAMIKA March 9, 2026

Psoriatic Arthritis Imaging Advancement: A New Scoring System & Global Collaboration

;